MERSANA THERAPEUTICS INC's ticker is MRSN and the CUSIP is 59045L106. A total of 130 filers reported holding MERSANA THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.05 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,937,182 | -81.8% | 2,312,742 | -52.9% | 0.00% | -100.0% |
| Q2 2023 | $16,137,940 | -38.8% | 4,905,149 | -23.5% | 0.00% | 0.0% |
| Q1 2023 | $26,354,232 | -61.6% | 6,412,222 | -45.3% | 0.00% | -50.0% |
| Q4 2022 | $68,633,034 | +150.1% | 11,712,122 | +188.5% | 0.00% | 0.0% |
| Q3 2022 | $27,439,000 | +266.5% | 4,059,020 | +150.5% | 0.00% | – |
| Q2 2022 | $7,486,000 | +38.8% | 1,620,330 | +19.8% | 0.00% | – |
| Q1 2022 | $5,395,000 | -79.4% | 1,352,150 | -68.0% | 0.00% | -100.0% |
| Q4 2021 | $26,252,000 | -31.9% | 4,220,557 | +3.2% | 0.00% | -50.0% |
| Q3 2021 | $38,571,000 | -12.5% | 4,090,196 | +26.0% | 0.00% | 0.0% |
| Q2 2021 | $44,088,000 | -27.3% | 3,246,523 | -13.3% | 0.00% | -33.3% |
| Q1 2021 | $60,610,000 | -27.8% | 3,746,000 | +18.7% | 0.00% | -40.0% |
| Q4 2020 | $83,951,000 | +53.0% | 3,154,884 | +7.1% | 0.01% | +25.0% |
| Q3 2020 | $54,872,000 | +49.8% | 2,946,913 | +88.2% | 0.00% | +33.3% |
| Q2 2020 | $36,632,000 | +806.3% | 1,565,449 | +125.8% | 0.00% | – |
| Q1 2020 | $4,042,000 | +13.6% | 693,327 | +11.7% | 0.00% | – |
| Q4 2019 | $3,557,000 | +275.6% | 620,685 | +3.5% | 0.00% | – |
| Q3 2019 | $947,000 | -56.5% | 599,660 | +11.5% | 0.00% | – |
| Q2 2019 | $2,179,000 | +116.4% | 537,903 | +180.9% | 0.00% | – |
| Q1 2019 | $1,007,000 | +40.4% | 191,490 | +8.9% | 0.00% | – |
| Q4 2018 | $717,000 | -61.1% | 175,808 | -4.6% | 0.00% | – |
| Q3 2018 | $1,843,000 | -40.8% | 184,197 | +5.8% | 0.00% | – |
| Q2 2018 | $3,111,000 | +31.6% | 174,177 | +16.1% | 0.00% | – |
| Q1 2018 | $2,364,000 | +225.6% | 149,982 | +240.2% | 0.00% | – |
| Q4 2017 | $726,000 | +80.6% | 44,088 | +89.8% | 0.00% | – |
| Q3 2017 | $402,000 | – | 23,231 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RHO CAPITAL PARTNERS INC | 796,458 | $14,830,000 | 12.35% |
| Consonance Capital Management LP | 3,468,171 | $64,577,000 | 7.87% |
| Sarissa Capital Management LP | 2,837,000 | $52,824,000 | 6.22% |
| Bain Capital Life Sciences Investors, LLC | 3,445,667 | $64,158,000 | 5.98% |
| Ghost Tree Capital, LLC | 1,050,000 | $19,551,000 | 5.65% |
| NEA Management Company, LLC | 5,959,520 | $110,966,000 | 4.70% |
| Soleus Capital Management, L.P. | 393,041 | $7,318,000 | 3.88% |
| ACUTA CAPITAL PARTNERS, LLC | 667,500 | $12,429,000 | 3.38% |
| Avoro Capital Advisors LLC | 6,800,000 | $126,616,000 | 1.80% |
| FNY Investment Advisers, LLC | 199,800 | $3,720,000 | 1.57% |